Odyssey Health ODYY
Odyssey Health FY 2024: net loss $842K; diluted EPS −$0.01
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001683168-24-007967
- Document
- 10-K
- Exhibit 10.32
- Form of promissory note amendment
- Exhibit 10.60
- Secured convertible promissory note - amendment 1
- Exhibit 10.61
- Secured convertible promissory note - amendment 2
- Exhibit 10.62
- Secured convertible promissory note - amendment 3
- Exhibit 10.63
- Pledge agreement
Key figures from this report
These are the numbers Odyssey Health reported for the year ended Jul 31, 2024, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Net income−$842KAgainst −$5.9M in FY 202310-K income statement, on EDGAR
- Diluted EPS−$0.01Against −$0.07 in FY 202310-K income statement, on EDGAR
- Cash and cash equivalents$2K−94% from $37K in FY 202310-K balance sheet, on EDGAR
- Cash from operations−$1.2MAgainst −$1.5M in FY 202310-K cash flow statement, on EDGAR
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Autonomix Medical AMIX public float $6M, Sep 30, 2025
- Sonoma Pharmaceuticals SNOA public float $6M, Sep 30, 2025
- Family Office of America FOFA public float $6M, Jun 30, 2025
- Adm Tronics Unlimited ADMT public float $7M, Sep 30, 2025
- Aethlon Medical AEMD public float $6M, Sep 30, 2025